Navigation Links
Research Publication Suggests Metadichol® Could Reverse Age Related Diseases.
Date:3/20/2019

Many companies are developing anti-aging drugs using telomerase activation, but Nanorx Inc is paving the way for safe clinical testing.

A recent publication in the Journal of Stem Cell Research & Therapy featured Metadichol®, an immune system booster developed by Nanorx Inc. that has shown promising results for the reversal of aging. The paper, entitled “Quest for Immortality Introducing Metadichol®, a Novel Telomerase Activator,” was published on March 5, 2019. The article describes the effect of Metadichol ® on telomerase expression profile on umbilical cord cells. It shows the optimistic research being performed on age reversal.

“As a long term user of Metadichol® for over 5 years, I have seen a 24 percent decrease in my biological age based on measurement of the telomeres length,” said Dr. P.R. Raghavan, Chairman, and CEO of Nanorx, Inc. “We have also seen positive changes in other long term users. Use of telomerase to reverse aging is promising and exciting, and we believe Metadichol® could pave the way for this new age.”

Public research suggests that telomerase, an enzyme that is found in the cell, is the key to the reversal of aging. Cell division is necessary for the making of new cells. Every time cells divide, they must duplicate their DNA, and telomerase adds repetitive caps called telomeres to the strand. With each division, a portion of the telomeres is shortened, which leads to age-related cellular breakdown. Without telomeres, chromosome ends may fuse and corrupt the cell's genetic blueprint, possibly causing malfunction, cancer, or cell death. Many companies are performing research to prevent telomeres shortening or to lengthen telomeres artificially.

Some companies have developed a procedure to deliver telomerase to cells with the insertion of modified viruses that carry the telomerase gene. This is complicated in practice, as gene therapy has adverse effects, and no human trials are known that express the ability to deliver telomerase effectively to human cells. Metadichol and its expression of telomerase delivery in-vivo to the blood overcomes the hurdles facing researchers in the field.

Metadichol® is an extract from food-based sources and is devoid of toxic effects, and it can be directly tested on humans. It is currently available in an easily absorbable emulsion with the name Metadichol and Nano-Ojas. Metadichol strengthens the immune system and restores balance to other vital functions including wound healing, stimulating cell regeneration and promoting healthy energy levels. Metadichol® acts on the vitamin D nuclear receptors of each cell like an active vitamin D and thus regulates up to 700+ genes of vital importance for the cellular life. Metadichol® paves the way for safe clinical testing and research of telomerase biology and provides enormous medical and financial benefits due to its use in fighting human diseases and reducing the rate of aging.

Nanorx Inc, has published many research papers on the effectiveness of Metadichol® in treating age-related diseases including the expression of Klotho, an anti-aging gene, and the inhibition of the BCAT1 gene, which is implicated in the aging process. The paper in the Journal of Stem Cell Research & Therapy showed that using q-RT-PCR techniques telomerase mRNA gene h-Tert expression showed a sixteen-fold increase at one picogram per ml concentration. Western blot studies showed the expression of Telomerase protein is being maintained at a replacement level. Aging is a law of nature and unavoidable. Instead of targeting a multitude of diseases that confront us as we age Metadichol is about correcting the root cause of diseases as exemplified by our patents and publications. Reversing aging is becoming more attainable, and the future is bright with Metadichol®. Ongoing research and work profiling of other long term users will be reported in an upcoming international conference later this year. The article on Metadichol® and how it potentially reverse signs of aging can be found at http://www.researchgate.net,. Or at http://www.academia.edu.

For licensing and marketing opportunities, contact Dr. P.R. Raghavan at raghavan(at)nanorxinc.com.

Nanorx a privately owned company founded in 2008 in New York that has developed a plant-based nano-eulsion of long-chain aliphatic alcohols, which improves the immune system and balances other vital functions. Metadichol® is covered by US patents and has been granted patents in many other countries. Visit https://www.nanoojas.net/ and http://www.gen100.com to view the company's products.

Read the full story at https://www.prweb.com/releases/research_publication_suggests_metadichol_could_reverse_age_related_diseases/prweb16176938.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. NYC Injury Lawyers Block O'Toole & Murphy Hosted Their 2013 Autumn Wine Tasting Event To Benefit St. Jude Children's Research Hospital And It Was A Huge Success
2. UT Southwestern researchers discover a new driver of breast cancer
3. Dartmouth researcher finds novel genetic patterns that make us rethink biology and individuality
4. Lip Balm for Chapped Lips Often Incorrectly Applied Reports Water and Health Researcher
5. Global In Vitro Fertilization Market 2012-2016 New Research Report at ReportsnReports.com
6. Researchers at Pace University Explore the Lived Experiences of Families Members That Have the Possible Risk of Genetic Mutations That Cause Sudden Cardiac Death
7. BCC Research Publishes a New Report on Global Markets for Influenza Products
8. Penn Medicine receives award from Patient-Centered Outcomes Research Institute
9. Researchers identify a histone demethylase associated with non-small cell lung cancer
10. Global Blood Collection Systems Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2016
11. Lean On Life Supports New Research That Reveals Common Personality Traits Contributing to Weight Gain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... August 21, 2019 , ... Alsana ... in Huntsville, Ala. in early 2020. Alsana will offer an eating disorder treatment ... Outpatient Program (IOP). The integrative program will provide a continuum of care as ...
(Date:8/21/2019)... ... August 21, 2019 , ... Future ... July 28. The Phase II expansion of Providence Point in Pittsburgh’s Scott Township ... as construction of the 70-unit apartment tower, Hamilton Tower. , The ...
(Date:8/19/2019)... ... 2019 , ... Professional Enrollment Concepts (PEC), a top benefits ... have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies list. The ... most successful companies within the American economy's most dynamic segment—its independent small and ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... Tim Stouffer, ICS ... Mid-Atlantic and North East at the 2019 Safety Academy sponsored through Associated Builders ... existing construction safety concepts and define not only a safety program but focus ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center has ... Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The one-day ... Heights, is aimed at helping Houston families get their children caught up on ...
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... Road in Gainesville GA, 30501, is a comprehensive family dental practice that serves ... within general dentistry, cosmetic dentistry , endodontics and restorative dental care. The ...
(Date:8/16/2019)... ... August 16, 2019 , ... OCT Clinical ... it has successfully completed enrollment of 690 patients for a phase III efficacy ... multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of MED2002, which ...
Breaking Medicine Technology: